These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8997576)

  • 41. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
    Miller IM; Vogel R; Cook TJ; Wittreich J
    Am J Ophthalmol; 1992 Jun; 113(6):638-44. PubMed ID: 1598954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.
    Kernt K; Martinez MA; Bertin D; Stroman D; Cupp G; Martínez C; Tirado M; Guasch J;
    Eur J Ophthalmol; 2005; 15(5):541-9. PubMed ID: 16167284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.
    Gross RD; Hoffman RO; Lindsay RN
    Clin Pediatr (Phila); 1997 Aug; 36(8):435-44. PubMed ID: 9272316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fusidic acid prophylaxis before cataract surgery: patient self-administration.
    Gray TB; Keenan JI; Clemett RS; Allardyce RA
    Aust N Z J Ophthalmol; 1993 May; 21(2):99-103. PubMed ID: 8333941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops.
    Dirdal M
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):129-33. PubMed ID: 3300139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.
    John T; Shah AA
    Ann Ophthalmol (Skokie); 2008; 40(2):68-74. PubMed ID: 19013912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coagulase-negative staphylococci in conjunctivitis and blepharitis.
    Au YK; Jensen HG; Rowsey J; Reynolds M
    Yan Ke Xue Bao; 1993 Sep; 9(3):129-35. PubMed ID: 8168607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fusidic acid viscous eyedrops--an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists.
    Doughty MJ; Dutton GN
    Ophthalmic Physiol Opt; 2006 Jul; 26(4):343-61. PubMed ID: 16792734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Four cases of Raoultella planticola conjunctivitis.
    Vassallo J; Vella M; Cassar R; Caruana P
    Eye (Lond); 2016 Apr; 30(4):632-4. PubMed ID: 26742869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group.
    Miller IM; Wittreich JM; Cook T; Vogel R
    Eye (Lond); 1992; 6 ( Pt 1)():111-4. PubMed ID: 1426394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis.
    Tsai AC; Tseng MC; Chang SW; Hu FR
    J Formos Med Assoc; 1995 Dec; 94(12):760-4. PubMed ID: 8541741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ophthalmic ciprofloxacin.
    Med Lett Drugs Ther; 1991 May; 33(845):52-3. PubMed ID: 2030657
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence and antibiotic susceptibility of bacteria isolated in patients affected with blepharitis in a tertiary eye centre in Spain.
    de Paula A; Oliva G; Barraquer RI; de la Paz MF
    Eur J Ophthalmol; 2020 Sep; 30(5):991-997. PubMed ID: 31232091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of chlamydial conjunctivitis].
    Aznabaev MT; Latypova EA; Babushkin AE
    Vestn Oftalmol; 2001; 117(5):51-2. PubMed ID: 11765472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re: The treatment of acute infectious conjunctivitis with fusidic acid.
    Rietveld RP; ter Riet G
    Br J Gen Pract; 2006 Mar; 56(524):222. PubMed ID: 16536964
    [No Abstract]   [Full Text] [Related]  

  • 57. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
    Prajna NV; George C; Selvaraj S; Lu KL; McDonnell PJ; Srinivasan M
    Cornea; 2001 Mar; 20(2):175-8. PubMed ID: 11248824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.
    Comstock TL; Paterno MR; Decory HH; Usner DW
    Clin Drug Investig; 2010; 30(10):675-85. PubMed ID: 20629472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blepharitis--a diagnostic and therapeutic challenge. A report on 407 consecutive cases.
    Huber-Spitzy V; Baumgartner I; Böhler-Sommeregger K; Grabner G
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):224-7. PubMed ID: 1831177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.